Skip to main content
. 2007 Apr 27;334(7601):987. doi: 10.1136/bmj.39166.597836.BE

Table 4.

 Mean difference in cognitive decline between aspirin and placebo groups during follow-up, from initial assessment

Cognitive test Mean difference (95% CI) P value
Global score*:
 From first to second assessment 0.01 (−0.02 to 0.05) 0.45
 From first to third assessment 0.01 (−0.03 to 0.04) 0.70
Average over follow-up 0.01 (−0.02 to 0.04) 0.50
Verbal memory score†:
 From first to second assessment 0.02 (−0.02 to 0.06) 0.38
 From first to third assessment −0.01 (−0.05 to 0.03) 0.73
Average over follow-up 0.01 (−0.03 to 0.04) 0.71
TICS test:
 From first to second assessment 0.01 (−0.13 to 0.16) 0.87
 From first to third assessment 0.04 (−0.12 to 0.20) 0.61
Average over follow-up 0.02 (−0.11 to 0.16) 0.71
Category fluency:
 From first to second assessment −0.01 (−0.28 to 0.25) 0.91
 From first to third assessment 0.25 (−0.02 to 0.52) 0.07
Average over follow-up 0.11 (−0.12 to 0.34) 0.34

TICS=telephone interview of cognitive status.

*Composite of five tests: TICS test, immediate and delayed recalls of east Boston memory test, delayed recall of 10 word list, and category fluency.

†Composite of four tests: immediate and delayed recalls of both 10 word list and east Boston memory test.